<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0011009'>Acute</z:hpo> inflammatory reactions cause neuronal damage in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion </plain></SENT>
<SENT sid="1" pm="."><plain>Urinary trypsin inhibitor (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e>), a serine <z:chebi fb="0" ids="37670">protease inhibitor</z:chebi>, is cytoprotective against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury in the liver, intestine, kidney, heart, and lung through its antiinflammatory activity </plain></SENT>
<SENT sid="2" pm="."><plain>Neuroprotective action of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> on transient global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> has been documented </plain></SENT>
<SENT sid="3" pm="."><plain>This is the first study to determine whether <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> is neuroprotective against transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Adult male Wistar rats were randomly assigned to the following treatment groups: 0.9% saline (control, n = 9); 100,000 U/kg <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> (n = 9); and 300,000 U/kg <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> (n = 9) </plain></SENT>
<SENT sid="5" pm="."><plain>Treatments were performed intravenously 10 min before right middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 2 h and subsequent reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain>Ninety-six hours after the <z:hpo ids='HP_0003674'>onset</z:hpo> of reperfusion, the motor neurologic deficit and the cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> size were evaluated </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, immunohistochemical staining for myeloperoxidase and nitrotyrosine to count infiltrating neutrophils and nitrated cells, respectively, was performed on the brain sections </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: <z:mpath ids='MPATH_124'>Infarct</z:mpath> volume in the 300,000 U/kg <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> group was smaller than in the 100,000 U/kg <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> and saline control groups (P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>Treatment with 300,000 U/kg <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> showed a trend to improve neurologic outcome but did not reach statistical significance (P = 0.0693) </plain></SENT>
<SENT sid="10" pm="."><plain>The significant decrease in neutrophil infiltration was observed in the ischemic hemisphere treated with 300,000 U/kg <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> compared with saline control (P &lt; 0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>Nitrotyrosine deposition in the ischemic hemisphere was significantly reduced in the 300,000 U/kg <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> group compared with saline control and 100,000 U/kg <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> groups (P &lt; 0.05) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Intravenous pretreatment with 300,000 U/kg <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> reduces focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury in the rat brain, potentially opening a novel therapeutic avenue for the treatment of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>